Type 2 Diabetes Mellitus and Hypertension

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · see citing works

Free Radicals in the Physiological Control of Cell Function

Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855 · see citing works

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663 · see citing works

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

(1998) · BMJ · doi:10.1136/bmj.317.7160.703 · Cited by 6,683 · see citing works

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial

Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728 · see citing works

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664 · see citing works

Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638 · see citing works

Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol

Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407 · see citing works

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125 · see citing works

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803 · see citing works

Standards of medical care in diabetes—2013

American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369 · see citing works

Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010.

Ogden, C., Carroll, M., Kit, B., & Flegal, K. (2012) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2012.40 · Cited by 4,128 · see citing works

Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063 · see citing works

Effects of intensive blood-pressure control in type 2 diabetes mellitus

(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598 · see citing works

Telmisartan, ramipril, or both in patients at high risk for vascular events

(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502 · see citing works

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy

(2000) · The Lancet · doi:10.1016/s0140-6736(99)12323-7 · Cited by 3,179 · see citing works

Treatment of hypertension in patients 80 years of age or older

Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092 · see citing works

Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61

Basevi, V., Mario, S. D., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,058 · see citing works

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

Dahlöf, B., Sever, P. S., Poulter, N. R., Wedel, H., Beevers, D. G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67185-1 · Cited by 2,909 · see citing works

Standards of medical care in diabetes—2011

American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880 · see citing works

Critical nodes in signalling pathways: insights into insulin action

Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · see citing works

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

Julius, S., Kjeldsen, S. E., Weber, M. A., Brunner, H. R., Ekman, S., Hansson, L., Hua, T. A., Laragh, J. H., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,546 · see citing works

Insulin Resistance in Essential Hypertension

Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344 · see citing works

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

(2010) · The Lancet · doi:10.1016/s0140-6736(10)62039-9 · Cited by 2,242 · see citing works

US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008

Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197 · see citing works

Untitled work

(2000) · PubMed · Cited by 2,095 · see citing works

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

Hansson, L., Lindholm, L. H., NISKANEN, L. K., Lanke, J., Hedner, T., Niklason, A., LUOMANMÄKI, K., Dahlöf, B., Fairé, U. D., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 1,991 · see citing works

Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials

Whelton, S. P., Chin, A., Xin, X., & He, J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00006 · Cited by 1,970 · see citing works

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924 · see citing works

Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms

Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652 · see citing works

Oxidative Stress and Vascular Disease

Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618 · see citing works

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560 · see citing works

Pharmacology, physiology, and mechanisms of incretin hormone action.

Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500 · see citing works

Diabetes, Hypertension, and Cardiovascular Disease

Sowers, J. R., Epstein, M., & Frohlich, E. D. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1053 · Cited by 1,331 · see citing works

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

Cook, N. R., Cutler, J. A., Obarzanek, E., Buring, J. E., Rexrode, K. M., Kumanyika, S. K., Appel, L. J., & Whelton, P. K. (2007) · BMJ · doi:10.1136/bmj.39147.604896.55 · Cited by 1,179 · see citing works

The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension

Estacio, R. O., Jeffers, B. W., Hiatt, W. R., Biggerstaff, S. L., Gifford, N., & Schrier, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381003 · Cited by 1,158 · see citing works

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.

Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075 · see citing works

Reactive Oxygen Species in the Vasculature

Taniyama, Y., & Griendling, K. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000100443.09293.4f · Cited by 1,067 · see citing works

Receptor-mediated regional sympathetic nerve activation by leptin.

Haynes, W. G., Morgan, D. A., Walsh, S. A., Mark, A. L., & Sivitz, W. I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119532 · Cited by 979 · see citing works

Effect of Diuretic-Based Antihypertensive Treatment on Cardiovascular Disease Risk in Older Diabetic Patients With Isolated Systolic Hypertension

Curb, J. D. (1996) · JAMA · doi:10.1001/jama.1996.03540230036032 · Cited by 955 · see citing works

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

Tuomilehto, J. O., Rastenytė, D., Birkenhäger, W. H., Thijs, L., Antikaínen, R., Bulpitt, C. J., FLETCHER, A. E., Forette, F., Goldhaber, A., Palatini, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400902 · Cited by 932 · see citing works

Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

Tatti, P., Pahor, M., Byington, R. P., Mauro, P. D., Guarisco, R., Strollo, G., & Strollo, F. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.597 · Cited by 843 · see citing works

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792 · see citing works

Ambulatory Blood-Pressure Monitoring

Pickering, T. G., Shimbo, D., & Haas, D. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra060433 · Cited by 786 · see citing works

Daytime and Nighttime Blood Pressure as Predictors of Death and Cause-Specific Cardiovascular Events in Hypertension

Fagard, R. H., Celis, H., Thijs, L., Staessen, J. A., Clement, D. L., De Buyzere, M. L., & De Bacquer, D. A. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100727 · Cited by 742 · see citing works

Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents

Gupta, A. K., Arshad, S., & Poulter, N. R. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.139816 · Cited by 681 · see citing works

Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease

Cooper-DeHoff, R. M., Gong, Y., Handberg, E. M., Bavry, A. A., Denardo, S. J., Bakris, G. L., & Pepine, C. J. (2010) · JAMA · doi:10.1001/jama.2010.884 · Cited by 651 · see citing works

[Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59].

Dominiak, M. (2008) · PubMed · Cited by 583 · see citing works

Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension

Mahfoud, F., Schlaich, M. P., Kindermann, I., Ukena, C., Cremers, B., Brandt, M. C., Hoppe, U. C., Vonend, O., Rump, L. C., Sobotka, P. A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.991869 · Cited by 572 · see citing works

Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor

Thorens, B., Porret, A., Bühler, L. H., Deng, S., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 552 · see citing works

Cardiovascular Biology of the Incretin System

Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 527 · see citing works

Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation

Massiéra, F., Bloch-Faure, M., Ceiler, D. L., Murakami, K., Fukamizu, A., Gasc, J., Quignard‐Boulangé, A., Négrel, R., Ailhaud, G. P., Seydoux, J., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0457fje · Cited by 505 · see citing works

T Regulatory Lymphocytes Prevent Angiotensin II–Induced Hypertension and Vascular Injury

Barhoumi, T., Kasal, D. A. B., Li, M. W., Shbat, L., Laurant, P., Neves, M. F., Paradis, P., & Schiffrin, E. L. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.162941 · Cited by 459 · see citing works

Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials

Bangalore, S., Kumar, S., Lobach, I., & Messerli, F. H. (2011) · Circulation · doi:10.1161/circulationaha.110.016337 · Cited by 437 · see citing works

Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy

Berl, T., Hunsicker, L. G., Lewis, J. B., Pfeffer, M. A., Porush, J. G., Rouleau, J. L., Drury, P., Esmatjes, E., Hricik, D. E., Parikh, C. R., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-7-200304010-00010 · Cited by 400 · see citing works

Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis

Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337 · see citing works

Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension

Boustany, C., Bharadwaj, K. G., Daugherty, A., Brown, D. R., Randall, D. C., & Cassis, L. A. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00265.2004 · Cited by 336 · see citing works

Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance

Cooper, S. A., Whaley-Connell, A., Habibi, J., Wei, Y., Lastra, G., Manrique, C., Stas, S., & Sowers, J. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00522.2007 · Cited by 317 · see citing works

Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production

Potenza, M. A., Marasciulo, F. L., Chieppa, D. M., Brigiani, G. S., Formoso, G., Quon, M. J., & Montagnani, M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00092.2005 · Cited by 314 · see citing works

Aldosterone mediates angiotensin II‐induced interstitial cardiac fibrosis via a Nox2‐containing NADPH oxidase

Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D., & Shah, A. M. (2006) · The FASEB Journal · doi:10.1096/fj.05-4642fje · Cited by 314 · see citing works

Effect of insulin on renal sodium and uric acid handling in essential hypertension

Muscelli, E. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00098-2 · Cited by 313 · see citing works

Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why)

Landsberg, L. (2001) · Journal of Hypertension · doi:10.1097/00004872-200103001-00001 · Cited by 310 · see citing works

Reduced Dietary Salt for the Prevention of Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials (Cochrane Review)

Taylor, R. S., Ashton, K. E., Moxham, T., Hooper, L., & Ebrahim, S. B. J. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.115 · Cited by 309 · see citing works

Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients

Azadbakht, L., Fard, N. R. P., Karimi, M., Baghaei, M. H., Surkan, P. J., Rahimi, M., Esmaillzadeh, A., & Willett, W. C. (2011) · Diabetes Care · doi:10.2337/dc10-0676 · Cited by 304 · see citing works

Kaplan's Clinical Hypertension

Kokot, F. (2002) · Arterial Hypertension · Cited by 288 · see citing works

Cardiovascular Outcomes in Framingham Participants With Diabetes

Chen, G., McAlister, F. A., Walker, R. L., Hemmelgarn, B. R., & Campbell, N. R. C. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.162446 · Cited by 284 · see citing works

Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes

TODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2420 · Cited by 279 · see citing works

Aldosterone and Vascular Inflammation

Brown, N. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.095489 · Cited by 253 · see citing works

Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes

Bilous, R., Chaturvedi, N., Sjølie, A. K., Fuller, J., Klein, R., Orchard, T., Porta, M., & Parving, H.-H. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-1-200907070-00120 · Cited by 251 · see citing works

Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension

Mahfoud, F., Ukena, C., Schmieder, R. E., Cremers, B., Rump, L. C., Vonend, O., Weil, J., Schmidt, M. U., Hoppe, U. C., Zeller, T., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000949 · Cited by 249 · see citing works

Ten-year incidence of elevated blood pressure and its predictors: The CARDIA Study

Dyer, A., Liu, K., Walsh, M. K., Kiefe, C. I., Jacobs, D. R., & Bild, D. (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000740 · Cited by 245 · see citing works

Ethnic Differences in Hypertension Incidence Among Middle-Aged and Older Adults

Carson, A. P., Howard, G., Burke, G. L., Shea, S., Levitan, E. B., & Muntner, P. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168005 · Cited by 245 · see citing works

Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes

Weber, M. A., Bakris, G. L., Jamerson, K., Weir, M., Kjeldsen, S. E., Devereux, R. B., Velazquez, E. J., Dahlöf, B., Kelly, R. Y., Hua, T. A., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.046 · Cited by 244 · see citing works

Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular Risks

Ogihara, T., Nakao, K., Fukui, T., Fukiyama, K., Ueshima, K., Oba, K., Sato, T. S., & Saruta, T. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.098475 · Cited by 241 · see citing works

Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium

Keske, M. A., Montagnani, M., & Quon, M. J. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0018-9 · Cited by 226 · see citing works

Effect of Sitagliptin, a Dipeptidyl Peptidase‐4 Inhibitor, on Blood Pressure in Nondiabetic Patients With Mild to Moderate Hypertension

Mistry, G. C., Maes, A. L., Lasseter, K. C., Davies, M. J., Gottesdiener, K. M., Wagner, J. A., & Herman, G. A. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008316885 · Cited by 208 · see citing works

Diabetes Mellitus and Vascular Disease

Sowers, J. R. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00612 · Cited by 206 · see citing works

Kaplan's Clinical Hypertension

Kaplan, N. M. (2002) · Cited by 197 · see citing works

Cardiac Function in Mice Lacking the Glucagon-Like Peptide-1 Receptor

Gros, R., You, X., Baggio, L. L., Kabir, M. G., Sadi, A. M., Mungrue, I. N., Parker, T. G., Huang, Q., Drucker, D. J., & Husain, M. (2003) · Endocrinology · doi:10.1210/en.2003-0007 · Cited by 192 · see citing works

Cardiovascular Disease Risk Factors, Type 2 Diabetes Mellitus, and the Framingham Heart Study

Fox, C. S. (2010) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2010.08.001 · Cited by 191 · see citing works

Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes

Redón, J., Mancia, G., Sleight, P., Schumacher, H., Gao, P., Pogue, J. M., Fagard, R. H., Verdecchia, P., Weber, M. A., Böhm, M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.040 · Cited by 188 · see citing works

Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes

The DECODE Study Group, & Hu, G. (2003) · Diabetologia · doi:10.1007/s00125-003-1096-6 · Cited by 184 · see citing works

The Dietary Approaches to Stop Hypertension Eating Plan Affects C-Reactive Protein, Coagulation Abnormalities, and Hepatic Function Tests among Type 2 Diabetic Patients

Azadbakht, L., Surkan, P. J., Esmaillzadeh, A., & Willett, W. C. (2011) · Journal of Nutrition · doi:10.3945/jn.110.136739 · Cited by 182 · see citing works

Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon–Like Peptide 1–Dependent Mechanism

Liu, L., Liu, J., Wong, W. T., Tian, X. Y., Lau, C. W., Wang, Y.-X., Xu, G., Pu, Y., Zhu, Z., Xu, A., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195115 · Cited by 179 · see citing works

Effectiveness of Home Telehealth in Comorbid Diabetes and Hypertension: A Randomized, Controlled Trial

Wakefield, B. J., Holman, J. E., Ray, A. L., Scherubel, M., Adams, M. R., Hillis, S. L., & Rosenthal, G. E. (2011) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2010.0176 · Cited by 174 · see citing works

Insulin action and insulin resistance in vascular endothelium

Muniyappa, R., & Quon, M. J. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32819f8ecd · Cited by 172 · see citing works

Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial

Leenen, F. H. H., Nwachuku, C. E., Black, H. R., Cushman, W. C., Davis, B. R., Simpson, L. M., Alderman, M. H., Atlas, S. A., Basile, J. N., Cuyjet, A. B., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000231662.77359.de · Cited by 171 · see citing works

A novel adipokine CTRP1 stimulates aldosterone production

Jeon, J. H., Kim, K., Kim, J. H., Baek, A., Cho, H., Lee, Y., Kim, J. W., Kim, D., Han, S. H., Lim, J., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-9412com · Cited by 167 · see citing works

Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database

Horton, E. S., Silberman, C., Davis, K. L., & Berria, R. (2010) · Diabetes Care · doi:10.2337/dc09-2062 · Cited by 156 · see citing works

Aldosterone: Role in the Cardiometabolic Syndrome and Resistant Hypertension

Whaley‐Connell, A. T., Johnson, M. S., & Sowers, J. R. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.12.004 · Cited by 152 · see citing works

50th Anniversary of Aldosterone

Williams, J. S., & Williams, G. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030490 · Cited by 150 · see citing works

Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001-2008.

Wright, J. D., Hughes, J. P., Ostchega, Y., Yoon, S. S., & Nwankwo, T. (2011) · PubMed · Cited by 147 · see citing works

Ambulatory blood pressure monitoring: which arm?

O’Shea, J., & Murphy, M. B. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000998 · Cited by 128 · see citing works

Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats

Pacheco, B. P. M., Crajoinas, R. O., Couto, G. K., Davel, A. P., Lessa, L. M. A., Rossoni, L. V., & Girardi, A. C. C. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328341939d · Cited by 124 · see citing works

Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease

Hu, G., Jousilahti, P., & Tuomilehto, J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm501 · Cited by 122 · see citing works

Emerging cardiovascular actions of the incretin hormone glucagon‐like peptide‐1: potential therapeutic benefits beyond glycaemic control?

Grieve, D., Cassidy, R. S., & Green, B. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00376.x · Cited by 121 · see citing works

Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat

Lastra, G., Whaley-Connell, A., Manrique, C., Habibi, J., Gutweiler, A. A., Appesh, L., Hayden, M. R., Wei, Y., Ferrario, C., & Sowers, J. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00258.2007 · Cited by 119 · see citing works

The Role of Overweight and Obesity in the Cardiorenal Syndrome

Sowers, J. R., Whaley‐Connell, A. T., & Hayden, M. R. (2011) · Cardiorenal Medicine · doi:10.1159/000322822 · Cited by 118 · see citing works

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

Östergren, J., Poulter, N. R., Sever, P. S., Dahlöf, B., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328310e0d9 · Cited by 116 · see citing works

Nebivolol Improves Diastolic Dysfunction and Myocardial Remodeling Through Reductions in Oxidative Stress in the Zucker Obese Rat

Zhou, X., Ma, L., Habibi, J., Whaley-Connell, A., Hayden, M. R., Tilmon, R. D., Brown, A. N., Kim, J.-A., DeMarco, V. G., & Sowers, J. R. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145136 · Cited by 116 · see citing works

Dipeptidylpeptidase Inhibition Is Associated with Improvement in Blood Pressure and Diastolic Function in Insulin-Resistant Male Zucker Obese Rats

Aroor, A. R., Sowers, J. R., Bender, S. B., Nistala, R., Garro, M., Mugerfeld, I., Hayden, M. R., Johnson, M. S., Salam, M., Whaley‐Connell, A. T., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1096 · Cited by 103 · see citing works

Spironolactone Prevents Chlorthalidone-Induced Sympathetic Activation and Insulin Resistance in Hypertensive Patients

Raheja, P., Price, A. L., Wang, Z., Arbique, D., ADAMS-HUET, B. A., Auchus, R. J., & Vongpatanasin, W. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.194787 · Cited by 100 · see citing works

Dehydroepiandrosterone Mimics Acute Actions of Insulin to Stimulate Production of Both Nitric Oxide and Endothelin 1 via Distinct Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase-Dependent Pathways in Vascular Endothelium

Formoso, G., Chen, H., Kim, J., Montagnani, M., Consoli, A., & Quon, M. J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0266 · Cited by 99 · see citing works

Dipeptidyl peptidase IV inhibition downregulates Na + -H + exchanger NHE3 in rat renal proximal tubule

Girardi, A. C. C., Fukuda, L. E., Rossoni, L. V., Malnic, G., & Rebouças, N. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00174.2007 · Cited by 99 · see citing works

Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats

Song, J., Hu, X., Riazi, S., Tiwari, S., Wade, J. B., & ECELBARGER, C. A. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00108.2005 · Cited by 96 · see citing works

Appropriate Blood Pressure Control in NIDDM (ABCD) Trial

Schrier, R. W., Estacio, R. O., & Jeffers, B. (1996) · Diabetologia · doi:10.1007/s001250050629 · Cited by 93 · see citing works

Role of aldosterone and angiotensin II in insulin resistance: an update

Lastra‐Lastra, G., Sowers, J. R., Restrepo‐Erazo, K., Manrique‐Acevedo, C., & Lastra‐González, G. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03498.x · Cited by 90 · see citing works

Small artery structure and function in hypertension

Heagerty, A. M., Heerkens, E. H. J., & Izzard, A. S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01080.x · Cited by 84 · see citing works

Impaired sodium excretion and increased blood pressure in mice with targeted deletion of renal epithelial insulin receptor

Tiwari, S., Sharma, N., Gill, P. S., Igarashi, P., Kahn, C. R., Wade, J. B., & ECELBARGER, C. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711283105 · Cited by 84 · see citing works

Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications

Cooper‐DeHoff, R. M., Wen, S., Beitelshees, A. L., Zineh, I., Gums, J. G., Turner, S. T., Gong, Y., Hall, K., Parekh, V., Chapman, A. B., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.139592 · Cited by 79 · see citing works

Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database

Bonora, E., Capaldo, B., Perin, P. C., Prato, S. D., Mattia, G. D., Frittitta, L., Frontoni, S., Leonetti, F., Luzi, L., Marchesini, G., et al. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.05.002 · Cited by 76 · see citing works

Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes

Ruggenenti, P. L., Perna, A., Ganeva, M. G., Ene‐Iordache, B., & Remuzzi, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060560 · Cited by 70 · see citing works

Effect of Change in Sodium Excretion on Change in Blood Pressure Corrected for Measurement Error: The Trials of Hypertension Prevention, Phase I

Cook, N. R., Kumanyika, S., & Cutler, J. A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009668 · Cited by 69 · see citing works

Greater Effect of Glycemia on Incidence of Hypertension in Women Than in Men

Haffner, S. M., Valdez, R. A., Morales, P. A., Mitchell, B. D., Hazuda, H. P., & D, M. P. S. M. (1992) · Diabetes Care · doi:10.2337/diacare.15.10.1277 · Cited by 66 · see citing works

Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells

Mukai, Y., Wang, C.-Y., Rikitake, Y., & Liao, J. K. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00868.2006 · Cited by 63 · see citing works

The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9–36)a in an isolated rat heart

Ossum, A. M., van Deurs, U., Engstrøm, T., Jensen, J. S., & Treiman, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.06.004 · Cited by 51 · see citing works

Intensive Blood Pressure Control Affects Cerebral Blood Flow in Type 2 Diabetes Mellitus Patients

Kim, Y.-S., Davis, S. C. A. T., Truijen, J., Stok, W. J., Secher, N. H., & LIESHOUT, J. J. V. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.160523 · Cited by 48 · see citing works

Thiazide Diuretics Alone or With β-Blockers Impair Glucose Metabolism in Hypertensive Patients With Abdominal Obesity

Manrique, C. M., Johnson, M. S., & Sowers, J. R. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.142620 · Cited by 38 · see citing works

VALUE: analysis of results

Staessen, J. A., Thijs, L., & Birkenhäger, W. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17010-4 · Cited by 33 · see citing works

Quality of life, depression, and healthcare resource utilization among adults with type 2 diabetes mellitus and concomitant hypertension and obesity: a prospective survey

Green, A. J., Bazata, D. D., Fox, K. M., & Grandy, S. (2012) · Cardiology Research and Practice · doi:10.1155/2012/404107 · Cited by 33 · see citing works

Evidence‐Based Hypertension Treatment in Patients With Diabetes

Garcia‐Touza, M., & Sowers, J. R. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00570.x · Cited by 29 · see citing works

Racial differences in hypertension-associated red cell sodium permeability

Etkin, N. L., Mahoney, J. R., Forsthoefel, M. W., Eckman, J. R., McSwigan, J. D., Gillum, R. F., & Eaton, J. W. (1982) · Nature · doi:10.1038/297588a0 · Cited by 24 · see citing works

Triple-Combination Therapy with Olmesartan, Amlodipine, and Hydrochlorothiazide in Black and Non-Black Study Participants with Hypertension

Chrysant, S. G., Littlejohn, T. W., Izzo, J. L., Kereiakes, D. J., Oparil, S., Melino, M. R., Lee, J., Fernandez, V., & Heyrman, R. (2012) · American Journal of Cardiovascular Drugs · doi:10.1007/bf03261832 · Cited by 23 · see citing works

Single-Pill Combination of Telmisartan/Amlodipine Versus Amlodipine Monotherapy in Diabetic Hypertensive Patients: An 8-Week Randomized, Parallel-Group, Double-Blind Trial

Sharma, A. M., Bakris, G. L., Neutel, J. M., Littlejohn, T. W., Kobe, M., Ting, N., & Ley, L. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.02.004 · Cited by 21 · see citing works

Renal nerves in blood pressure regulation

Johns, E. J., & Abdulla, M. H. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283641a89 · Cited by 21 · see citing works

Lifestyle Changes Through the Use of Delivered Meals and Dietary Counseling in a Single-Blind Study

Noda, K., Zhang, B., Iwata, A., Nishikawa, H., Ogawa, M., Nomiyama, T., Miura, S., Sako, H., Matsuo, K., Yahiro, E., et al. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0164 · Cited by 20 · see citing works

Triple-Combination Therapy with Olmesartan, Amlodipine, and Hydrochlorothiazide in Black and Non-Black Study Participants with Hypertension

Chrysant, S. G., Littlejohn, T. W., Izzo, J. L., et al. (2012) · American Journal of Cardiovascular Drugs · doi:10.2165/11634160-000000000-00000 · Cited by 19 · see citing works

Is the Association of Diabetes With Uncontrolled Blood Pressure Stronger in Mexican Americans and Blacks Than in Whites Among Diagnosed Hypertensive Patients?

Liu, X., & Song, P. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt109 · Cited by 17 · see citing works

The burden of illness of hypertension and comorbid diabetes

Eaddy, M. T., Shah, M. B., Lunacsek, O. E., & Stanford, R. H. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802297529 · Cited by 13 · see citing works

Generic Medications and Blood Pressure Control in Diabetic Hypertensive Subjects

Cummings, D. M., Letter, A. J., Howard, G., Howard, V. J., Safford, M. M., Prince, V., & Muntner, P. (2012) · Diabetes Care · doi:10.2337/dc12-0755 · Cited by 12 · see citing works

SMALL ARTERY STRUCTURE AND FUNCTION IN HYPERTENSION

Heagerty, S. B. W. A. M. (2014) · CRC Press eBooks · doi:10.1201/b17072-21 · Cited by 7 · see citing works

VALUE: analysis of results

Fretheim, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17015-3 · Cited by 5 · see citing works

La restriction sodée prévient le remodelage cardiovasculaire dans l’insulinorésistance chez le rat

Rugale, C., Oudot, C., Desmetz, C., Guzman, C., Lajoix, A., & Jover, B. F. (2013) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2013.03.001 · Cited by 3 · see citing works

Type 2 diabetes mellitus

DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611 · see citing works

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

Chilton, R., Tikkanen, I., Cannon, C. P., Crowe, S., Woerle, H. J., Broedl, U. C., & Johansen, O. E. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12572 · Cited by 507 · see citing works

A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives

Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441 · see citing works

Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease

Jia, G., & Sowers, J. R. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17981 · Cited by 459 · see citing works

Glomerular hyperfiltration

Cortinovis, M., Perico, N., Ruggenenti, P., Remuzzi, A., & Remuzzi, G. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00559-y · Cited by 214 · see citing works

Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial

Saxena, A. R., Gorman, D. N., Esquejo, R. M., Bergman, A., Chidsey, K., Buckeridge, C., Griffith, D. A., & Kim, A. M. (2021) · Nature Medicine · doi:10.1038/s41591-021-01391-w · Cited by 156 · see citing works

Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese

Tatsumi, Y., & Ohkubo, T. (2017) · Hypertension Research · doi:10.1038/hr.2017.67 · Cited by 148 · see citing works

Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC)

Kemps, H., Kränkel, N., Dörr, M., Moholdt, T. T., Wilhelm, M., Paneni, F., Serratosa, L., Solberg, E. E., Hansen, D., Halle, M., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487318820420 · Cited by 147 · see citing works

Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis

Pfeifer, M. A., Townsend, R. R., Davies, M. J., Vijapurkar, U., & Ren, J. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0511-0 · Cited by 131 · see citing works

High prevalence of diabetes mellitus, hypertension and obesity among persons with a recorded diagnosis of intellectual disability or autism spectrum disorder

Wallén, E. F., Ljunggren, G., Carlsson, A. C., Pettersson, D. R., & Wändell, P. E. (2017) · Journal of Intellectual Disability Research · doi:10.1111/jir.12462 · Cited by 130 · see citing works

Diabetes and Cardiovascular Disease: an Update

Almourani, R., Chinnakotla, B., Patel, R., Kurukulasuriya, L. R., & Sowers, J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1239-x · Cited by 114 · see citing works

Beyond the Gut: Unveiling Butyrate’s Global Health Impact Through Gut Health and Dysbiosis-Related Conditions: A Narrative Review

Kalkan, A. E., BinMowyna, M. N., Raposo, A., Ahmad, M. F., Ahmed, F., Otayf, A. Y., Carrascosa, C., Saraiva, A., & Karav, S. (2025) · Nutrients · doi:10.3390/nu17081305 · Cited by 109 · see citing works

PGE2, Kidney Disease, and Cardiovascular Risk

Nasrallah, R., Hassouneh, R., & Hébert, R. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050528 · Cited by 98 · see citing works

Diabetes-Associated Comorbidities

Teck, J. (2022) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2021.11.004 · Cited by 86 · see citing works

Prevalence of prediabetes and diabetes mellitus among adults residing in Cameroon: A systematic review and meta-analysis

Bigna, J. J., Nansseu, J. R., Katte, J.-C. N., & Noubiap, J. J. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.005 · Cited by 84 · see citing works

Health system readiness for non-communicable diseases at the primary care level: a systematic review

Kabir, A., Karim, M. N., Islam, R. M., Romero, L., & Billah, B. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060387 · Cited by 77 · see citing works

Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications

Bell, D. S. H., & Gonçalves, E. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13652 · Cited by 73 · see citing works

The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma

Yuwono, N. L., Warton, K., & Ford, C. E. (2021) · eLife · doi:10.7554/elife.69679 · Cited by 71 · see citing works

Effects and Mechanisms of Tea Regulating Blood Pressure: Evidences and Promises

Li, D., Wang, R., Huang, J., Cai, Q., Yang, C. S., Wan, X., & Xie, Z. (2019) · Nutrients · doi:10.3390/nu11051115 · Cited by 75 · see citing works

The Association of Age at Diagnosis of Hypertension With Brain Structure and Incident Dementia in the UK Biobank

Shang, X., Hill, E., Zhu, Z., Liu, J., Ge, Z., Wang, W., & He, M. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17608 · Cited by 70 · see citing works

Prevalence of, and risk factors for, diabetes and prediabetes in Bangladesh: Evidence from the national survey using a multilevel Poisson regression model with a robust variance

Hossain, M. B., Khan, M. N., Oldroyd, J. C., Rana, J., Magliano, D. J., Chowdhury, E., Karim, M. N., & Islam, R. M. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000461 · Cited by 67 · see citing works

Arterial hypertension in Turner syndrome

Groote, K. D., Demulier, L., Backer, J. F. A. D., Wolf, D. D., Schepper, J. D., T'Sjoen, G. G., & Backer, T. L. M. D. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000599 · Cited by 66 · see citing works

Adverse pregnancy outcomes associated with first‐trimester exposure to angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta‐analysis

Buawangpong, N., Teekachunhatean, S., & Koonrungsesomboon, N. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.644 · Cited by 66 · see citing works

Impact of sodium–glucose cotransporter 2 inhibitors on blood pressure

Reed, J. W. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s111991 · Cited by 65 · see citing works

Autophagy: A housekeeper in cardiorenal metabolic health and disease

Jia, G., & Sowers, J. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.025 · Cited by 58 · see citing works

Gender differences and determinants of prevalence, awareness, treatment and control of hypertension among adults in China and Sweden

Santosa, A., Zhang, Y., Weinehall, L., Zhao, G., Wang, N., Zhao, Q., Wang, W., & Ng, N. (2020) · BMC Public Health · doi:10.1186/s12889-020-09862-4 · Cited by 58 · see citing works

Zinc deficiency induces hypertension by promoting renal Na+ reabsorption

Williams, C. R., Mistry, M., Cheriyan, A. M., Williams, J. M., Naraine, M., Ellis, C. L., Mallick, R., Mistry, A. C., Gooch, J. L., Ko, B. S., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00487.2018 · Cited by 57 · see citing works

Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program

Shamanna, P., Dharmalingam, M., Sahay, R. K., Mohammed, J., Mohamed, M., Poon, T., Kleinman, N. L., & Thajudeen, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-94339-6 · Cited by 56 · see citing works

Pathophysiological Links Between Diabetes and Blood Pressure

Libianto, R., Batu, D., MacIsaac, R. J., Cooper, M. E., & Ekinci, E. I. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.01.010 · Cited by 54 · see citing works

Antioxidant Roles of SGLT2 Inhibitors in the Kidney

Llorens-Cebrià, C., den Bosch, M. M. V., Vergara, A., Jacobs-Cachá, C., & Soler, M. J. (2022) · Biomolecules · doi:10.3390/biom12010143 · Cited by 54 · see citing works

Common metabolic features of hypertension and type 2 diabetes

Usui, I. (2023) · Hypertension Research · doi:10.1038/s41440-023-01233-x · Cited by 56 · see citing works

Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study

Joseph, J. J., Echouffo-Tcheugui, J. B., Kalyani, R. R., Yeh, H.-C., Bertoni, A. G., Effoe, V. S., Casanova, R., Sims, M., Correa, A., Wu, W.-C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1002 · Cited by 51 · see citing works

Effects of sodium‐glucose cotransporter‐2 inhibitors on the cardiovascular and renal complications of type 2 diabetes

CHILTON, R. J. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13854 · Cited by 50 · see citing works

Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of SGLT2-inhibitors and GLP1-receptor agonists

Berra, C., Manfrini, R., Regazzoli, D., Radaelli, M. G., Disoteo, O., Sommese, C., Fiorina, P., Ambrosio, G., & Folli, F. B. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105052 · Cited by 49 · see citing works

Diabetes mellitus and hypertension

Oktay, A. A., Aktürk, H. K., & Jahangir, E. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000297 · Cited by 47 · see citing works

The Association between Hypertension Comorbidity and Microvascular Complications in Type 2 Diabetes Patients: A Nationwide Cross-Sectional Study in Thailand

Hurst, C. P., Thinkhamrop, B., & Tran, H. T. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.5.395 · Cited by 48 · see citing works

Reasons for low utilisation of public facilities among households with hypertension: analysis of a population-based survey in India

Kujawski, S. A., Leslie, H. H., Prabhakaran, D., Singh, K., & Kruk, M. E. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2018-001002 · Cited by 44 · see citing works

Association of Genetic Variations in NRF2, NQO1, HMOX1, and MT with Severity of Coronary Artery Disease and Related Risk Factors

Sarutipaiboon, I., Settasatian, N., Komanasin, N., Kukongviriyapan, U., Sawanyawisuth, K., Intharaphet, P., Senthong, V., & Settasatian, C. (2019) · Cardiovascular Toxicology · doi:10.1007/s12012-019-09544-7 · Cited by 43 · see citing works

Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis

Wiciński, M., Górski, K. M., Wódkiewicz, E., Walczak, M., Nowaczewska, M., & Malinowski, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072275 · Cited by 44 · see citing works

Causal relationship between gut microbiota and type 2 diabetes: a two-sample Mendelian randomization study

Li, H., & Li, C. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1184734 · Cited by 42 · see citing works

Cardioprotective and anti-inflammatory effects of G-protein coupled receptor 30 (GPR30) on postmenopausal type 2 diabetic rats

Azizian, H., Khaksari, M., Asadikaram, G., Esmailidehaj, M., & Farhadi, Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.028 · Cited by 43 · see citing works

Assessment of drug related problems among type 2 diabetes mellitus patients with hypertension in Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia

Ayele, Y., Melaku, K., Dechasa, M., Ayalew, M. B., & Horsa, B. A. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3838-z · Cited by 42 · see citing works

RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus

Kumar, V., Agarwal, S., Saboo, B., & Makkar, B. M. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01143-7 · Cited by 45 · see citing works

Kepatuhan Terhadap Pengobatan Pasien Diabetes Melitus Tipe 2 di Puskesmas Jakarta Timur

Saibi, Y., Romadhon, R., & Nasir, N. M. (2020) · Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) · doi:10.22487/j24428744.2020.v6.i1.15002 · Cited by 69 · see citing works

Type 2 diabetes mellitus, its impact on quality of life and how the disease can be managed-a review

Garg, P., & Duggal, N. (2022) · Obesity Medicine · doi:10.1016/j.obmed.2022.100459 · Cited by 50 · see citing works

The C1q/TNF-related proteins (CTRPs) in pathogenesis of obesity-related metabolic disorders: Focus on type 2 diabetes and cardiovascular diseases

Shanaki, M., Shabani, P., Goudarzi, A., Omidifar, A., Bashash, D., & Emamgholipour, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117913 · Cited by 38 · see citing works

Neuroprotective Properties of Linagliptin: Focus on Biochemical Mechanisms in Cerebral Ischemia, Vascular Dysfunction and Certain Neurodegenerative Diseases

Wiciński, M., Górski, K. M., Walczak, M., Wódkiewicz, E., Słupski, M., Pawlak-Osińska, K., & Malinowski, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164052 · Cited by 35 · see citing works

Prevalence and associated factors of diabetic foot ulcers among type 2 diabetic patients attending chronic follow-up clinics at governmental hospitals of Harari Region, Eastern Ethiopia: A 5-year (2013–2017) retrospective study

Tola, A., Regassa, L. D., & Ayele, Y. (2021) · SAGE Open Medicine · doi:10.1177/2050312120987385 · Cited by 34 · see citing works

Exploring the Mediating Effect of Physical Activities on Built Environment and Obesity for Elderly People: Evidence From Shanghai, China

Xiao, Y., Chen, S., Miao, S., & Yu, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.853292 · Cited by 32 · see citing works

Population attributable fractions of the main type 2 diabetes mellitus risk factors in women: Findings from the French E3N cohort

Rajaobelina, K., Dow, C., Mancini, F. R., Dartois, L., Boutron‐Ruault, M., Balkau, B., Bonnet, F., & Fagherazzi, G. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12839 · Cited by 30 · see citing works

The effect of cocoa/dark chocolate consumption on lipid profile, glycemia, and blood pressure in diabetic patients: A meta‐analysis of observational studies

Darand, M., Oghaz, M. H., Hadi, A., Atefi, M., & Amani, R. (2021) · Phytotherapy Research · doi:10.1002/ptr.7183 · Cited by 31 · see citing works

Phenotypic Modulation of Mesenteric Vascular Smooth Muscle Cells from Type 2 Diabetic Rats is Associated with Decreased Caveolin-1 Expression

Carrillo-Sepúlveda, M. A., & Matsumoto, T. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366354 · Cited by 30 · see citing works

Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study

Wan, E., Yu, E., Chin, W. Y., Fung, C., Fong, D., Choi, E. P., Chan, A. K. L., & Lam, C. (2018) · Diabetes Care · doi:10.2337/dc17-2443 · Cited by 31 · see citing works

High Glucose Stimulates Mineralocorticoid Receptor Transcriptional Activity Through the Protein Kinase C β Signaling

Hayashi, T., Shibata, H., Kurihara, I., Yokota, K., Mitsuishi, Y., Ohashi, K., Murai‐Takeda, A., Jo, R., Ohyama, T., Sakamoto, M., et al. (2017) · International Heart Journal · doi:10.1536/ihj.16-649 · Cited by 30 · see citing works

Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease

Shen, Y. H., Dai, Y., Wang, X. Q., Zhang, R., Lu, L., Ding, F. H., & Shen, W. F. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0959-1 · Cited by 30 · see citing works

Pathophysiology and Prevention of Heart Disease in Diabetes Mellitus

Oktay, A. A., Aktürk, H. K., Esenboğa, K., Javed, F., Polin, N. M., & Jahangir, E. (2017) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2017.05.001 · Cited by 32 · see citing works

Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney

Luo, J., Hu, S., Fu, M., Luo, L., Li, Y., Li, W., Cai, Y., Dong, R., Yang, Y., Tu, L., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100667 · Cited by 26 · see citing works

Multi-organ denervation: a novel approach to combat cardiometabolic disease

Kiuchi, M. G., Carnagarin, R., Matthews, V. B., & Schlaich, M. P. (2023) · Hypertension Research · doi:10.1038/s41440-023-01287-x · Cited by 27 · see citing works

Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes

Goulopoulou, S., Hannan, J. L., Matsumoto, T., Ogbi, S. N., Ergul, A., & Webb, R. C. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00079.2015 · Cited by 26 · see citing works

Type 2 Diabetes, Change in Depressive Symptoms Over Time, and Cerebral Small Vessel Disease: Longitudinal Data of the AGES-Reykjavik Study

Rensma, S. P., van Sloten, T. T., Ding, J., Sigurdsson, S. O., Stehouwer, C. D. A., Gudnason, V. G., & Launer, L. J. (2020) · Diabetes Care · doi:10.2337/dc19-2437 · Cited by 25 · see citing works

Association between Adiponectin Gene Polymorphism and Environmental Risk Factors of Type 2 Diabetes Mellitus among the Chinese Population in Hohhot

Cui, M., Gao, Y., Zhao, Y., Pang, H., Chen, L., Wang, Z., Zhao, L., & Li, M. (2020) · BioMed Research International · doi:10.1155/2020/6383906 · Cited by 25 · see citing works

HbA1c – A predictor of dyslipidemia in type 2 Diabetes Mellitus

Kidwai, S. S., Nageen, A., Bashir, F., & Ara, J. (2020) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.6.2000 · Cited by 25 · see citing works

Bypassing TBI: Metabolic Surgery and the Link between Obesity and Traumatic Brain Injury—a Review

McGlennon, T. W., Buchwald, J. N., Pories, W. J., Yu, F., Roberts, A. J., Ahnfeldt, E. P., Menon, R., & Buchwald, H. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05065-3 · Cited by 25 · see citing works

Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study)

Sabuncu, T., Sönmez, A., Eren, M. A., Sahin, I., Çorapçioğlu, D., Üçler, R., Akin, Ş., Haymana, C., Demirci, İ., Atmaca, A., et al. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.11.001 · Cited by 25 · see citing works

Effects of Coexistence Hypertension and Type II Diabetes on Heart Rate Variability and Cardiorespiratory Fitness

Dibai, D. B., Cabiddu, R., Mendes, R. G., Tossini, N. B., Arakelian, V. M., Caruso, F., Júnior, J. C. B., Arena, R. A., & Borghi‐Silva, A. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180105 · Cited by 25 · see citing works

Cardiovascular risk in Turner syndrome

Donato, B., & Ferreira, M. J. (2018) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.08.008 · Cited by 29 · see citing works

miR-503/Apelin-12 mediates high glucose-induced microvascular endothelial cells injury via JNK and p38MAPK signaling pathway

Chen, K., Zhao, X.-L., Li, L.-B., Huang, L., Tang, Z., Luo, J., Yang, L., Qin, A.-P., & Hu, F. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2019.12.002 · Cited by 25 · see citing works

Bariatric surgery outcomes: is age just a number?

Athanasiadis, D. I., Hernandez, E., Monfared, S., Kubicki, N. S., Ninad, N., Karim, A., Selzer, D. J., Stefanidis, D., & Banerjee, A. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07752-9 · Cited by 27 · see citing works

Understanding the peroxisome proliferator-activated receptor gamma (PPAR-γ) role in periodontitis and diabetes mellitus: A molecular perspective

Nicchio, I. G., Cirelli, T., Quil, L. C. D. C., Camilli, Â. C., Scarel‐Caminaga, R. M., & Leite, F. R. M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116908 · Cited by 27 · see citing works

Diabetes and Hypertension: Clinical Update

Khangura, D., Kurukulasuriya, L. R., Whaley‐Connell, A. T., & Sowers, J. R. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy025 · Cited by 24 · see citing works

Social Support for Self-Care: Patient Strategies for Managing Diabetes and Hypertension in Rural Uganda

Tusubira, A. K., Nalwadda, C. K., Akiteng, A. R., Hsieh, E., Ngaruiya, C., Rabin, T. L., Katahoire, A., Hawley, N. L., Kalyesubula, R., Ssinabulya, I., et al. (2021) · Annals of Global Health · doi:10.5334/aogh.3308 · Cited by 24 · see citing works

Interaction of Hypertension and Insulin Resistance Exacerbates the Occurrence of Diabetes Mellitus in Healthy Individuals

Wang, B., Yang, Y., & Li, X. (2022) · Journal of Diabetes Research · doi:10.1155/2022/9289812 · Cited by 24 · see citing works

Activated monocytes as a therapeutic target to attenuate vascular inflammation and lower cardiovascular disease-risk in patients with type 2 diabetes: A systematic review of preclinical and clinical studies

Ngcobo, S. R., Nkambule, B. B., Nyambuya, T. M., Mokgalaboni, K., Ntsethe, A., Mxinwa, V., Ziqubu, K., Ntamo, Y., Nyawo, T. A., & Dludla, P. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112579 · Cited by 23 · see citing works

Type 2 diabetes mellitus reduces clinical complications and mortality in Stanford type B aortic dissection after thoracic endovascular aortic repair: A 3-year follow-up study

Liu, H., Shi, L., Zeng, T., Ji, Q., Shi, Y., Huang, Y., Zhang, L., Xiao, T., Ye, J., Lin, Y., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.055 · Cited by 22 · see citing works

Variant rs2237892 of KCNQ1 is Potentially Associated with Hypertension and Macrovascular Complications in Type 2 Diabetes Mellitus in a Chinese Han Population

Zhang, W., Wang, H., Guan, X., Niu, Q., & Li, W. (2015) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.05.004 · Cited by 22 · see citing works

Treatments for diabetes mellitus type II: New perspectives regarding the possible role of calcium and cAMP interaction

Carvalho, D. S., de Almeida, A. A., Borges, A. F., & Campos, D. V. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.04.002 · Cited by 22 · see citing works

Real-World Hypertension Prevalence, Awareness, Treatment, and Control in Adult Diabetic Individuals: An Italian Nationwide Epidemiological Survey

The Italian Society of Hypertension and Federfarma, Feo, M. D., Pinto, R. D., Pagliacci, S., Grassi, D., & Ferri, C. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00449-7 · Cited by 22 · see citing works

Association between height and hypertension in the adult Nepalese population: Findings from a nationally representative survey

Gupta, R. D., Haider, S. S., Hashan, M. R., Rahman, M. A., & Sarker, M. (2019) · Health Science Reports · doi:10.1002/hsr2.141 · Cited by 21 · see citing works

Glycosylation of IgG Associates with Hypertension and Type 2 Diabetes Mellitus Comorbidity in the Chinese Muslim Ethnic Minorities and the Han Chinese

Meng, X., Song, M., Vilaj, M. Ć., Štambuk, J., Mamatyusupu, D., Zhang, J., Liu, D., Wang, H., Zhang, X., Zhang, J., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070614 · Cited by 21 · see citing works

MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone

Kara, S. P., Ozkan, G., Yılmaz, A., Bayrakçı, N., Güzel, S., & Geyik, E. (2021) · Renal Failure · doi:10.1080/0886022x.2021.1915800 · Cited by 21 · see citing works

Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development

Paczkowska‐Walendowska, M., Sip, S., Staszewski, R., & Cielecka‐Piontek, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074156 · Cited by 20 · see citing works

Serum Ischemia-Modified Albumin, Fibrinogen, High Sensitivity C- Reactive Proteins in Type-2 Diabetes Mellitus without Hypertension and Diabetes Mellitus with Hypertension: A Case-Control Study

Sushith, S., Krishnamurthy, H. N., Reshma, S., Dsa, J., Madan, G. R., Ashok, K. J., Prathima, M. B., & Kalal, B. S. (2020) · Reports of Biochemistry and Molecular Biology · doi:10.29252/rbmb.9.2.241 · Cited by 19 · see citing works

Цукровий діабет і артеріальна гіпертензія

Сергієнко, В. О., & Serhiyenko, O. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.2.2021.230573 · Cited by 24 · see citing works

Association of Greenness with Blood Pressure among Individuals with Type 2 Diabetes across Rural to Urban Community Types in Pennsylvania, USA

Poulsen, M. N., Schwartz, B. S., Nordberg, C. M., DeWalle, J., Pollak, J., Imperatore, G., Mercado, C. I., Siegel, K. R., & Hirsch, A. G. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020614 · Cited by 18 · see citing works

Association of neck circumference and hypertension among adults in a rural community Thailand: A cross-sectional study

Soitong, P., Jangjaicharoen, S., Kaewsanit, A., Mali, P., Viriyakhaikul, Y., Boonnumma, S., Tipmabutr, S., Chalermchuang, P., Maneechot, W., Numnoi, C., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256260 · Cited by 16 · see citing works

Assessment of the risk factors associated with type 2 diabetes and prediabetes mellitus: A national survey in Vietnam

Phan, D., Vu, T., Doan, V. T., Le, T., Nguyen, T., & Hoang, M. T. V. (2022) · Medicine · doi:10.1097/md.0000000000031149 · Cited by 16 · see citing works

Heart failure and diabetes: Clinical significance and epidemiology of this two‐way association

Jerkins, T. W., McGill, J. B., & Bell, D. S. H. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15062 · Cited by 16 · see citing works

Anti-atherosclerotic effect of incretin receptor agonists

Wang, X., Yang, X., Qi, X., Fan, G., Zhou, L., Peng, Z., & Yang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1463547 · Cited by 19 · see citing works

Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Indian Guideline 2024 by Association of Physicians of India and Indian College of Physicians

Wander, G. S., Panda, J. K., Pal, J., Mathur, G., Sahay, R. K., TIWASKAR, M. H., Chatterjee, N., Chakrabarty, S., Singh, D. P., Murthy, L. S., et al. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0620 · Cited by 16 · see citing works

Gestational hypertension and chronic hypertension on the risk of diabetes among gestational diabetes women

Yuan, X., Liu, H., Wang, L., Zhang, S., Zhang, C., Leng, J., Dong, L., Lv, L., Lv, F., Tian, H., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.04.025 · Cited by 15 · see citing works

Molecular biochemical aspects of salt (sodium chloride) in inflammation and immune response with reference to hypertension and type 2 diabetes mellitus

Das, U. N. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01507-8 · Cited by 16 · see citing works

Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia

Kefale, B., Tegegne, G. T., Kefale, Y., Molla, M., Ewunetei, A., & Degu, A. (2020) · SAGE Open Medicine · doi:10.1177/2050312120954695 · Cited by 14 · see citing works

How Perturbated Metabolites in Diabetes Mellitus Affect the Pathogenesis of Hypertension?

Ning, Z., Song, Z., Wang, C., Peng, S., Wan, X., Liu, Z., & Lü, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.705588 · Cited by 15 · see citing works

The association between type 2 diabetes and anhedonic subtype of major depression in hypertensive individuals

Willame, H., Wacquier, B., Point, C., Dosogne, M., Faker, M. A., Loas, G., & Hein, M. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14411 · Cited by 13 · see citing works

Rising trends in the predicted 10-year risk of cardiovascular diseases among Royal Thai Army personnel from 2017 to 2021

Sakboonyarat, B., Poovieng, J., Jongcherdchootrakul, K., Srisawat, P., Hatthachote, P., Mungthin, M., & Rangsin, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-28494-3 · Cited by 14 · see citing works

Mild cognitive impairment in combination with comorbid diabetes mellitus and hypertension is negatively associated with health-related quality of life among older persons in Taiwan

Liu, H., Tsai, W., Chiu, M., Tang, L., Lee, H.-J., & Shyu, Y. L. (2019) · Quality of Life Research · doi:10.1007/s11136-019-02101-3 · Cited by 14 · see citing works

Multimorbidade de doenças cardiometabólicas e climatério: prevalência, padrões de doença e efeitos do exercício físico

Dechichi, J. (2022) · doi:10.14393/ufu.te.2022.5349 · Cited by 14 · see citing works

Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures

Lundgren, J. R., Færch, K., Witte, D. R., Jonsson, A. E., Pedersen, O. B., Hansen, T. F., Lauritzen, T., Holst, J. J., Vistisen, D., Jørgensen, M. E., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0937-7 · Cited by 13 · see citing works

Effects of green cardamom supplementation on serum levels of Hs-CRP, dimethylarginine, nitric oxide and blood pressure in patients with type 2 diabetes: A randomized, double-blind, placebo controlled, clinical trial

Zahedi, S. G., Koohdani, F., Qorbani, M., Nasli‐Esfahani, E., Aghasi, M., Khoshamal, H., Keshavarz, A. A., & Sotoudeh, G. (2022) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2022.100555 · Cited by 13 · see citing works

Exogenous H2S Attenuates Hypertension by Regulating Renin Exocytosis under Hyperglycaemic and Hyperlipidaemic Conditions

Liu, N., Li, M., Liu, S., Kang, J., Chen, L., Huang, J., Wang, Y., Chen, H., & Zhang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021690 · Cited by 13 · see citing works

Diabetic Hypertension

Khan, K. A., Govindarajan, G., Whaley‐Connell, A. T., & Sowers, J. R. (2006) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.11.002 · Cited by 4 · see citing works

Hypertension in type 2 diabetes mellitus

Hayden, M. R., & Sowers, J. R. (2006) · Insulin · doi:10.1016/s1557-0843(06)80005-9 · Cited by 21 · see citing works

Diabetes and hypertension: the bad companions

Ferrannini, E., & Cushman, W. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60987-8 · Cited by 696 · see citing works

Hypertension and Diabetes: Emphasis on the Renin – Angiotensin System and Insulin Resistance

Nistala, P., Nistala, R., Manrique, C. M., Lastra, G., & Sowers, J. (2009) · Current Hypertension Reviews · doi:10.2174/157340209788921185

Hypertension and Type 2 Diabetes

Redón, J., & Martínez, F. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_3 · Cited by 1 · see citing works